Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Triomi Medical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Triomi Medical

Triomi Medical

Seed

NYC-based Triomi offers a portable 12-lead EKG, integrating with smart devices for on-the-go heart disease diagnosis.

HQ
New York City, NY, US
Founded
2014
Accelerator
Techstars logoTechstars2015
Overview
Compare
Fundraising
Employees
Website

Founded in New York City, Triomi Medical aims to revolutionize heart disease diagnosis with its portable 12-lead EKG device. The company's core mission is to provide healthcare practitioners with a reliable, cost-effective tool for on-the-go heart disease diagnosis. Triomi's EKG device integrates seamlessly with various smart devices, including iPhone, Android, Windows, and Mac platforms, allowing for immediate reading and interpretation of results. The market focus includes private practices, home care settings, ambulances, and hospitals.

Notable affiliated individuals and investors have not been disclosed publicly. However, Triomi Medical has achieved significant milestones by improving patient care through its innovative product. The compact and user-friendly design of the Triomi 12-Lead EKG has made it an essential tool for healthcare providers, enhancing diagnostic accuracy and efficiency. The overall impact of Triomi Medical is evident in its contribution to timely and accurate heart disease diagnosis, ultimately saving lives and reducing healthcare costs.

Triomi Medical - Similar Companies

Altrix Medical logo

Altrix Medical

altrixmedical.com

QT Medical logo

QT Medical

qtmedical.com

Trireme Medical logo

Trireme Medical

Strohl Medical Technologies logo

Strohl Medical Technologies

strohlmedical.com

Remmie logo

Remmie

remmiehealth.com

Steth IO logo

Steth IO

stethio.com

Trice Medical logo

Trice Medical

tricemedical.com

Atrility Medical logo

Atrility Medical

atrility.com

Triopsy Medical logo

Triopsy Medical

3dbiopsy.com

Cardiac Insight logo

Cardiac Insight

Inspire Living logo

Inspire Living

AliveCor logo

AliveCor

alivecor.com

MobileMedTek logo

MobileMedTek

AugMI Labs logo

AugMI Labs

Heartio logo

Heartio

heartio.ai

Triomi Medical - Quick Facts

Who are Triomi Medical's competitors?

Companies similar to Triomi Medical include Altrix Medical, QT Medical, Trireme Medical and Strohl Medical Technologies.

When was Triomi Medical founded?

Triomi Medical was founded in 2014.

Where is Triomi Medical's headquarters located?

Triomi Medical's headquarters is located in New York City, NY, US.

When was Triomi Medical's last funding round?

Triomi Medical's most recent funding round was for $120k (USD) in March 2015.

How much has Triomi Medical raised to-date?

As of Mar 9, 2015, Triomi Medical has raised a total of $120k (USD).

How many employees does Triomi Medical have?

Triomi Medical has 5 employees as of Feb 4, 2024.

Triomi Medical - Classification

Industry
  • Hardware
Technology
  • Telemedicine
Geographic Exposure
  • Americas
Revenue
  • Recurring
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 7 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software